Cargando…
Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography
Understanding the mechanisms underlying progression in multiple sclerosis (MS) is one of the key elements contributing to the identification of appropriate therapeutic targets for this under-managed condition. In addition to plaque-related focal inflammatory pathology typical for relapsing remitting...
Autores principales: | Airas, Laura, Nylund, Marjo, Rissanen, Eero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879102/ https://www.ncbi.nlm.nih.gov/pubmed/29632509 http://dx.doi.org/10.3389/fneur.2018.00181 |
Ejemplares similares
-
Innate Immune Cell–Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis
por: Misin, Olavi, et al.
Publicado: (2022) -
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis
por: Polvinen, Eero, et al.
Publicado: (2023) -
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
por: Sucksdorff, Marcus, et al.
Publicado: (2020) -
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET
por: Nylund, Marjo, et al.
Publicado: (2021) -
Natalizumab treatment reduces microglial activation in the white matter of the MS brain
por: Sucksdorff, Marcus, et al.
Publicado: (2019)